ESR1 and breast carcinoma: In this context, the current study was designed to investigate the cytotoxicity, clonogenicity, and migration effects of protodioscin and dioscin in two molecular class subtypes, ER+ (MCF-7) and TNBC (MDA-MB-468) breast cancer cells.